These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

80 related items for PubMed ID: 1465311

  • 1. A model to assess the risk of recurrences of superficial bladder carcinoma. A preliminary report based on 27 patients with a two-year follow-up.
    Boccafoschi C, Robutti F, Montefiore F, Betta PG.
    Pathologica; 1992; 84(1091):269-73. PubMed ID: 1465311
    [Abstract] [Full Text] [Related]

  • 2. Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis.
    Huncharek M, McGarry R, Kupelnick B.
    Anticancer Res; 2001; 21(1B):765-9. PubMed ID: 11299841
    [Abstract] [Full Text] [Related]

  • 3. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial.
    Divrik RT, Yildirim U, Zorlu F, Ozen H.
    J Urol; 2006 May; 175(5):1641-4. PubMed ID: 16600720
    [Abstract] [Full Text] [Related]

  • 4. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer.
    Gofrit ON, Shapiro A, Pode D, Sidi A, Nativ O, Leib Z, Witjes JA, van der Heijden AG, Naspro R, Colombo R.
    Urology; 2004 Mar; 63(3):466-71. PubMed ID: 15028439
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.
    Witjes WP, Witjes JA, Oosterhof GO, Debruyne MJ.
    Semin Urol Oncol; 1996 Feb; 14(1 Suppl 1):10-6. PubMed ID: 8727805
    [Abstract] [Full Text] [Related]

  • 7. Recurrence, progression and success in stage Ta grade 3 bladder tumors treated with low dose bacillus Calmette-Guerin instillations.
    Lebret T, Bohin D, Kassardjian Z, Herve JM, Molinie V, Barre P, Lugagne PM, Botto H.
    J Urol; 2000 Jan; 163(1):63-7. PubMed ID: 10604315
    [Abstract] [Full Text] [Related]

  • 8. Risk factors for local recurrence in patients with pTa/pT1 urinary bladder cancer.
    Jancke G, Damm O, Rosell J, Jahnson S.
    Scand J Urol Nephrol; 2008 Jan; 42(5):417-21. PubMed ID: 18609266
    [Abstract] [Full Text] [Related]

  • 9. [A clinical study of recurrence and progression of grade 3 superficial bladder tumor].
    Ikegami S, Tsuji A, Suzuki S, Sumitomo M, Kimura F, Asano T, Nakajima F, Hayakawa M.
    Hinyokika Kiyo; 1999 May; 45(5):325-9. PubMed ID: 10410314
    [Abstract] [Full Text] [Related]

  • 10. Impact of tumour grade, stage, number and size, smoking habits and sex on the recurrence rate and disease-free interval in patients with transitional cell carcinoma of the bladder.
    Raitanen MP, Tammela TL.
    Ann Chir Gynaecol; 1995 May; 84(1):37-41. PubMed ID: 7645909
    [Abstract] [Full Text] [Related]

  • 11. Prognostic factors for primary superficial transitional cell carcinoma of the bladder: a retrospective cohort study.
    Yang TB, Zeng FH, Sun ZQ.
    Chin Med J (Engl); 2006 Nov 05; 119(21):1821-8. PubMed ID: 17097038
    [Abstract] [Full Text] [Related]

  • 12. [Initial conservative treatment for grade 3 Ta-1 superficial bladder cancer].
    Fujimoto K, Chihara Y, Kondo H, Hirao Y.
    Hinyokika Kiyo; 2006 Jun 05; 52(6):433-8. PubMed ID: 16848356
    [Abstract] [Full Text] [Related]

  • 13. Up-front intravesical chemotherapy for low stage, low grade recurrent bladder cancer.
    Maffezzini M, Simonato A, Zanon M, Raber M, Carmignani G.
    J Urol; 1996 Jan 05; 155(1):91-3. PubMed ID: 7490907
    [Abstract] [Full Text] [Related]

  • 14. TUR and adjuvant intravesical chemotherapy in T1G3 bladder tumors: recurrence, progression and survival in 137 selected patients followed up to 20 years.
    Serretta V, Pavone C, Ingargiola GB, Daricello G, Allegro R, Pavone-Macaluso M.
    Eur Urol; 2004 Jun 05; 45(6):730-5; discussion 735-6. PubMed ID: 15149744
    [Abstract] [Full Text] [Related]

  • 15. [Modern follow-up strategies for the treatment of patients with superficial bladder carcinoma].
    Werner W, Smesny S, Schubert J.
    Z Arztl Fortbild Qualitatssich; 2000 Aug 05; 94(6):519-27. PubMed ID: 10996943
    [Abstract] [Full Text] [Related]

  • 16. Significant predictive factors for prognosis of primary upper urinary tract cancer after radical nephroureterectomy in Taiwanese patients.
    Li CC, Chang TH, Wu WJ, Ke HL, Huang SP, Tsai PC, Chang SJ, Shen JT, Chou YH, Huang CH.
    Eur Urol; 2008 Nov 05; 54(5):1127-34. PubMed ID: 18243511
    [Abstract] [Full Text] [Related]

  • 17. Immunoprophylactic intravesical application of bacillus Calmette-Guerin after transurethral resection of superficial bladder cancer.
    Librenjak D, Situm M, Eterovic D, Dogas Z, Gotovac J.
    Croat Med J; 2003 Apr 05; 44(2):187-92. PubMed ID: 12698510
    [Abstract] [Full Text] [Related]

  • 18. [Short-term versus long-term chemoprevention of recurrence with Epodyl following transurethral resection of superficial urinary bladder cancer].
    Flamm J, Kühnel W, Dona S.
    Urologe A; 1989 Mar 05; 28(2):99-102. PubMed ID: 2655259
    [Abstract] [Full Text] [Related]

  • 19. Does the management of bladder perforation during transurethral resection of superficial bladder tumors predispose to extravesical tumor recurrence?
    Skolarikos A, Chrisofos M, Ferakis N, Papatsoris A, Dellis A, Deliveliotis C.
    J Urol; 2005 Jun 05; 173(6):1908-11. PubMed ID: 15879773
    [Abstract] [Full Text] [Related]

  • 20. [Tumors of the bladder in women. Epidemiologic and therapeutic aspects. Apropos of 40 cases].
    Rabii R, el Moussaoui A, Rais H, Joual A, Debbagh A, el Mrini M, Benjelloun S.
    Ann Urol (Paris); 1998 Jun 05; 32(3):166-71. PubMed ID: 9657034
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.